Bellouard Ronan

Bellouard Ronan

Biologie médicale

Hôpital Hôtel-Dieu Nantes
Nantes, France

43 Activités

31 Followers

Scientifique

Digital

Production scientifique

Activités par an

Expertise

Sujets de recherche

Endocardite Méningite Infection croisée Endocardite bactérienne COVID-19 Méningite bactérienne Infections à staphylocoques Maladie grave Alcoolisme

Collaborateurs

Voir plus

Hôpital Hôtel-Dieu Nantes, Nantes, France

Boutoille David

Hôpital Hôtel-Dieu Nantes, Nantes, France

Deslandes Guillaume

Hôpital Hôtel-Dieu Nantes, Nantes, France

Le Turnier Paul

Centre Hospitalier de Cayenne, Cayenne, France

Industries

Voir plus

Correvio

2 collaboration(s)

Dernière en 2021

{{person.topindus2.name}}

{{person.topindus2.tot}} collaboration(s)

Dernière en {{person.topindus2.last}}

{{person.topindus3.name}}

{{person.topindus3.tot}} collaboration(s)

Dernière en {{person.topindus3.last}}

{{person.topindus4.name}}

{{person.topindus4.tot}} collaboration(s)

Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus

Dalbavancin plasma concentrations in 133 patients: a PK/PD observational study.

The Journal of antimicrobial chemotherapy 21 octobre 2023

Development and validation of a dosing nomogram for continuous infusion cloxacillin in infective endocarditis

Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, 12–14 June 2023, Limoges, France 07 juin 2023

Development of an a priori tool to determine the frequency of dalbavancin administrations using a population pharmacokinetic approach

Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, 12–14 June 2023, Limoges, France 07 juin 2023

A priori optimization of levofloxacin dose regimen based on a population pharmacokinetics model

Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, 12–14 June 2023, Limoges, France 07 juin 2023

NOMOBA: An on-going multicentric study evaluating model-informed nomograms for a priori dose adaptation of amoxicillin, cloxacillin and cefazolin for the treatment of Gram-positive cocci bacteremia and infective endocarditis

Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, 12–14 June 2023, Limoges, France 07 juin 2023

Dalbavancin plasma concentrations in 133 patients: A PK-PD observational study

Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, 12–14 June 2023, Limoges, France 07 juin 2023

A multifaceted strategy to optimize pharmacokinetics of antimicrobial therapy in patients with hospital-acquired infections-a monocentre quality improvement project.

The Journal of antimicrobial chemotherapy 02 juin 2023

Concentrations plasmatiques des β-lactamines dans le traitement des endocardites infectieuses, doit-on faire mieux ? Plaidoyer pour le développement d'outils d'ajustement posologique a priori.

Journées Nationales de l'Infectiologie 2023 01 mai 2023

Development and validation of a dosing nomogram for continuous infusion cloxacillin in infective endocarditis.

The Journal of antimicrobial chemotherapy 04 avril 2023

Development of a Predictive Dosing Nomogram to Achieve PK/PD Targets of Amikacin Initial Dose in Critically Ill Patients: A Non-Parametric Approach.

Antibiotics (Basel, Switzerland) 09 janvier 2023